HUE036290T2 - Többkarú polimer vegyületek - Google Patents
Többkarú polimer vegyületekInfo
- Publication number
- HUE036290T2 HUE036290T2 HUE04784560A HUE04784560A HUE036290T2 HU E036290 T2 HUE036290 T2 HU E036290T2 HU E04784560 A HUE04784560 A HU E04784560A HU E04784560 A HUE04784560 A HU E04784560A HU E036290 T2 HUE036290 T2 HU E036290T2
- Authority
- HU
- Hungary
- Prior art keywords
- arm polymer
- polymer prodrugs
- prodrugs
- arm
- polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/595—Polyamides, e.g. nylon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50367303P | 2003-09-17 | 2003-09-17 | |
US58430804P | 2004-06-30 | 2004-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE036290T2 true HUE036290T2 (hu) | 2018-06-28 |
Family
ID=34381082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE04784560A HUE036290T2 (hu) | 2003-09-17 | 2004-09-17 | Többkarú polimer vegyületek |
Country Status (18)
Country | Link |
---|---|
US (4) | US7744861B2 (hu) |
EP (2) | EP2626083A1 (hu) |
JP (4) | JP5632119B2 (hu) |
KR (2) | KR101200729B1 (hu) |
CN (2) | CN1852740B (hu) |
AU (2) | AU2004274489B2 (hu) |
BR (1) | BRPI0414017B8 (hu) |
CA (1) | CA2537336C (hu) |
CY (1) | CY1119303T1 (hu) |
DK (1) | DK1675622T3 (hu) |
ES (1) | ES2629696T3 (hu) |
HR (1) | HRP20171094T1 (hu) |
HU (1) | HUE036290T2 (hu) |
LT (1) | LT1675622T (hu) |
PL (1) | PL1675622T3 (hu) |
PT (1) | PT1675622T (hu) |
SI (1) | SI1675622T1 (hu) |
WO (1) | WO2005028539A2 (hu) |
Families Citing this family (121)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060177416A1 (en) | 2003-10-14 | 2006-08-10 | Medivas, Llc | Polymer particle delivery compositions and methods of use |
US8394813B2 (en) | 2000-11-14 | 2013-03-12 | Shire Llc | Active agent delivery systems and methods for protecting and administering active agents |
US7169752B2 (en) * | 2003-09-30 | 2007-01-30 | New River Pharmaceuticals Inc. | Compounds and compositions for prevention of overdose of oxycodone |
US20060014697A1 (en) * | 2001-08-22 | 2006-01-19 | Travis Mickle | Pharmaceutical compositions for prevention of overdose or abuse |
US8133881B2 (en) | 2003-01-13 | 2012-03-13 | Shire Llc | Carbohydrate conjugates to prevent abuse of controlled substances |
PT1675622T (pt) | 2003-09-17 | 2017-09-19 | Nektar Therapeutics | Pró-fármacos de polímeros de múltiplos braços |
US8394365B2 (en) | 2003-09-17 | 2013-03-12 | Nektar Therapeutics | Multi-arm polymer prodrugs |
US9492400B2 (en) | 2004-11-04 | 2016-11-15 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
ES2350258T3 (es) * | 2005-05-11 | 2011-01-20 | Nippon Kayaku Kabushiki Kaisha | Derivado polimérico de un antagonista metabólico de la citidina. |
WO2006130978A1 (en) | 2005-06-06 | 2006-12-14 | The University Of British Columbia | Polymer-based serum albumin substitute |
EP1898955A2 (en) | 2005-06-17 | 2008-03-19 | Nektar Therapeutics AL, Corporation | Polymer-based compositions and conjugates of non-steroidal anti-inflammatory drugs |
EP1926780B1 (en) | 2005-09-22 | 2013-08-14 | Medivas, LLC | Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use |
JP5178520B2 (ja) * | 2005-09-22 | 2013-04-10 | メディバス エルエルシー | 固体ポリマー送達組成物およびその使用法 |
WO2007067744A2 (en) * | 2005-12-07 | 2007-06-14 | Medivas, Llc | Method for assembling a polymer-biologic delivery composition |
WO2007070682A2 (en) | 2005-12-15 | 2007-06-21 | Massachusetts Institute Of Technology | System for screening particles |
US9603941B2 (en) * | 2006-01-24 | 2017-03-28 | Minghui Chai | Method of preparing dendritic drugs |
US7462627B2 (en) * | 2006-02-09 | 2008-12-09 | Enzon Pharmaceuticals, Inc. | Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
US7671067B2 (en) * | 2006-02-09 | 2010-03-02 | Enzon Pharmaceuticals, Inc. | Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin |
CN101420963B (zh) * | 2006-02-09 | 2012-09-05 | 安佐制药股份有限公司 | 用于治疗乳腺癌、结肠直肠癌、胰腺癌、卵巢癌和肺癌的7-乙基-10-羟基喜树碱的多臂聚合轭合物 |
EP3222142A1 (en) | 2006-02-28 | 2017-09-27 | Kodiak Sciences Inc. | Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation |
CA2649672C (en) * | 2006-05-02 | 2015-07-07 | Medivas, Llc | Delivery of ophthalmologic agents to the exterior or interior of the eye |
JP5196498B2 (ja) * | 2006-05-09 | 2013-05-15 | メディバス エルエルシー | 生分解性水溶性ポリマー |
JP5630998B2 (ja) | 2006-05-15 | 2014-11-26 | マサチューセッツ インスティテュート オブ テクノロジー | 機能的粒子のためのポリマー |
WO2007150030A2 (en) | 2006-06-23 | 2007-12-27 | Massachusetts Institute Of Technology | Microfluidic synthesis of organic nanoparticles |
CA2669541C (en) | 2006-11-30 | 2014-11-18 | Nektar Therapeutics Al, Corporation | Method for preparing a polymer conjugate |
EP2134830A2 (en) | 2007-02-09 | 2009-12-23 | Massachusetts Institute of Technology | Oscillating cell culture bioreactor |
AU2008213576B2 (en) * | 2007-02-09 | 2013-01-17 | Enzon Pharmaceuticals, Inc. | Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
JP5428017B2 (ja) * | 2007-03-23 | 2014-02-26 | 国立大学法人 熊本大学 | ワクチン剤 |
JP2010523595A (ja) | 2007-04-04 | 2010-07-15 | マサチューセッツ インスティテュート オブ テクノロジー | ポリ(アミノ酸)ターゲッティング部分 |
US9241998B2 (en) * | 2007-05-21 | 2016-01-26 | Board Of Regents, The University Of Texas System | Methods and compositions for treatment of cancer using oncolytic RSV activity |
EP2178944A1 (en) * | 2007-07-24 | 2010-04-28 | Medivas, LLC | Biodegradable cationic polymer gene transfer compositions and methods of use |
KR20100051722A (ko) * | 2007-08-20 | 2010-05-17 | 엔즌 파마슈티칼스, 인코포레이티드 | 피리딜 이황화 부분을 포함하는 폴리머 링커 |
CA2713185A1 (en) * | 2007-08-23 | 2009-02-26 | Medivas, Llc | Cationic alpha-amino acid-containing biodegradable polymer gene transfer compositions |
WO2009043027A2 (en) * | 2007-09-27 | 2009-04-02 | Serina Therapeutics, Inc. | Multi-armed forms of activated polyoxazoline and methods of synthesis thereof |
WO2009051837A2 (en) | 2007-10-12 | 2009-04-23 | Massachusetts Institute Of Technology | Vaccine nanotechnology |
US8853247B2 (en) | 2007-11-02 | 2014-10-07 | Nektar Therapeutics | Oligomer-nitroimidazole anti-infective conjugates |
EP2268315B1 (en) * | 2008-03-31 | 2019-07-31 | Freie Universität Berlin | Drug conjugates with polyglycerols |
EP2216049A1 (en) * | 2009-02-06 | 2010-08-11 | Freie Universität Berlin | Drug conjugates with polyglycerols |
JP2011516503A (ja) * | 2008-04-07 | 2011-05-26 | インターフェース バイオロジクス,インコーポレーテッド | 細菌感染症を治療するための併用療法 |
EP2331140B1 (en) * | 2008-08-11 | 2018-07-04 | Nektar Therapeutics | Multi-arm polymeric alkanoate conjugates |
EP2323671A4 (en) * | 2008-08-13 | 2012-09-26 | Medivas Llc | BIODEGRADABLE AABB POLY (DEPSIPEPTIDE) POLYMERS AND METHOD FOR THEIR USE |
TW201010732A (en) * | 2008-08-29 | 2010-03-16 | Enzon Pharmaceuticals Inc | Method of treating RAS associated cancer |
US20110165112A1 (en) * | 2008-09-19 | 2011-07-07 | Nektar Therapeutics | Polymer conjugates of c-peptides |
US20110166063A1 (en) | 2008-09-19 | 2011-07-07 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
CA2736939C (en) * | 2008-09-23 | 2021-09-14 | Nektar Therapeutics | Means of achieving sustained-therapeutic sn-38 concentrations in a subject |
US8277812B2 (en) | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
US8591905B2 (en) | 2008-10-12 | 2013-11-26 | The Brigham And Women's Hospital, Inc. | Nicotine immunonanotherapeutics |
US8343498B2 (en) | 2008-10-12 | 2013-01-01 | Massachusetts Institute Of Technology | Adjuvant incorporation in immunonanotherapeutics |
US8343497B2 (en) | 2008-10-12 | 2013-01-01 | The Brigham And Women's Hospital, Inc. | Targeting of antigen presenting cells with immunonanotherapeutics |
US20100098654A1 (en) * | 2008-10-21 | 2010-04-22 | Fabio Pastorino | Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
KR20100083632A (ko) * | 2009-01-14 | 2010-07-22 | 울산대학교 산학협력단 | 표적 단백질 분해효소 감응형 항암제 전구체 |
KR20120094546A (ko) * | 2009-05-04 | 2012-08-24 | 인터자인 테크놀로지스, 인코포레이티드 | 종양 치료를 위한 sn―38을 함유하는 폴리머 미셀 |
EP2456464A4 (en) * | 2009-07-22 | 2013-02-20 | Enzon Pharmaceuticals Inc | METHODS OF TREATING POSITIVE HER2 CANCER WITH HER2 RECEPTOR ANTAGONIST IN COMBINATION WITH 7-ETHYL-10-HYDROXYCAMPTOTHECIN MULTI-ARM POLYMERIC CONJUGATES |
US8722732B2 (en) | 2009-09-29 | 2014-05-13 | Nektar Therapeutics | Oligomer-calcimimetic conjugates and related compounds |
CN102711836B (zh) * | 2009-11-18 | 2017-05-10 | 尼克塔治疗公司 | 酸式盐形式的聚合物‑药物偶联物和烷氧基化方法 |
WO2011075185A1 (en) | 2009-12-18 | 2011-06-23 | Oligasis | Targeted drug phosphorylcholine polymer conjugates |
CN102906157B (zh) | 2010-03-01 | 2016-08-24 | 不列颠哥伦比亚大学 | 衍生的超支化聚丙三醇 |
CN103119055A (zh) | 2010-05-17 | 2013-05-22 | 塞比克斯公司 | 聚乙二醇化c肽 |
CN102339813A (zh) | 2010-07-14 | 2012-02-01 | 中国科学院微电子研究所 | 半导体结构及其制造方法 |
EP2593021A4 (en) * | 2010-07-16 | 2018-01-24 | Kensey Nash Corporation | Bioadhesive compounds and methods of synthesis and use |
EP2598171A2 (en) * | 2010-07-28 | 2013-06-05 | Smartcells, Inc. | Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
US8524215B2 (en) * | 2010-08-02 | 2013-09-03 | Janssen Biotech, Inc. | Absorbable PEG-based hydrogels |
US20140371258A1 (en) * | 2010-12-17 | 2014-12-18 | Nektar Therapeutics | Water-Soluble Polymer Conjugates of Topotecan |
JP5899241B2 (ja) | 2010-12-21 | 2016-04-06 | ネクター セラピューティクス | ペメトレキセドベースの化合物のマルチアームポリマープロドラッグコンジュゲート |
WO2012088445A1 (en) | 2010-12-22 | 2012-06-28 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
US20130331443A1 (en) | 2010-12-22 | 2013-12-12 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
US9827326B2 (en) * | 2010-12-23 | 2017-11-28 | Nektar Therapeutics | Polymer-sunitinib conjugates |
JP6009457B2 (ja) | 2010-12-23 | 2016-10-19 | ネクター セラピューティクス | ポリマー−デスエチルスニチニブコンジュゲート |
CA2836915A1 (en) | 2011-05-20 | 2012-11-29 | Howard University | Emetine derivatives, prodrugs containing same, and methods of treating conditions using same |
WO2012166555A1 (en) | 2011-05-27 | 2012-12-06 | Nektar Therapeutics | Water - soluble polymer - linked binding moiety and drug compounds |
EP2723357A4 (en) * | 2011-06-21 | 2015-04-01 | Bvw Holding Ag | MEDICAL DEVICE COMPRISING BOSWELLIC ACID |
US9873765B2 (en) | 2011-06-23 | 2018-01-23 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
JP6045575B2 (ja) | 2011-06-23 | 2016-12-14 | ディーエスエム アイピー アセッツ ビー.ブイ. | 薬物送達のための新規な生分解性ポリエステルアミドコポリマー |
AU2012296949B2 (en) | 2011-08-12 | 2016-09-15 | Ascendis Pharma A/S | High-loading water-soluble carrier-linked prodrugs |
CA2843503C (en) | 2011-08-12 | 2020-12-22 | Ulrich Hersel | Polymeric hyperbranched carrier-linked prodrugs |
CN102935066B (zh) * | 2011-08-16 | 2014-09-17 | 齐鲁制药有限公司 | 一种伊立替康脂质体制剂及其制备方法 |
JP6138140B2 (ja) * | 2011-10-25 | 2017-05-31 | ネクター セラピューティクス | 癌患者の治療 |
US8383093B1 (en) * | 2011-11-01 | 2013-02-26 | Serina Therapeutics, Inc. | Subcutaneous delivery of poly(oxazoline) conjugates |
CN103083680B (zh) | 2011-11-07 | 2014-12-24 | 北京键凯科技有限公司 | 聚乙二醇-氨基酸寡肽-依诺替康药物结合物及其药物组合物 |
RU2493848C1 (ru) * | 2012-06-14 | 2013-09-27 | Геннадий Петрович Власов | Биодеградируемый полимерный носитель для доставки противоопухолевого лекарственного средства (варианты) |
JP6300460B2 (ja) * | 2012-07-20 | 2018-03-28 | キヤノン株式会社 | 化合物、および前記化合物を有する光音響イメージング用造影剤 |
EP2926137B1 (en) * | 2012-11-28 | 2019-05-29 | Nektar Therapeutics | Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase i inhibitor |
US9863949B2 (en) | 2013-05-31 | 2018-01-09 | Nektar Therapeutics | Method for predicting and evaluating responsiveness to cancer treatment with DNA-damaging chemotherapeutic agents |
US10195153B2 (en) | 2013-08-12 | 2019-02-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
WO2015035342A2 (en) | 2013-09-08 | 2015-03-12 | Oligasis Llc | Factor viii zwitterionic polymer conjugates |
JP5721806B2 (ja) * | 2013-10-04 | 2015-05-20 | Delta−Fly Pharma株式会社 | 副作用のない抗癌剤 |
SG11201602258WA (en) | 2013-10-04 | 2016-04-28 | Prolynx Llc | Slow-release conjugates of sn-38 |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US10653689B2 (en) * | 2014-01-14 | 2020-05-19 | Nektar Therapeutics | Combination-based treatment method |
US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
EP3169315B1 (en) | 2014-07-17 | 2020-06-24 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
CN107208076A (zh) | 2014-10-17 | 2017-09-26 | 科达制药 | 丁酰胆碱酯酶两性离子聚合物缀合物 |
US20160106737A1 (en) | 2014-10-20 | 2016-04-21 | Pharmaceutical Manufacturing Research Services, Inc. | Extended Release Abuse Deterrent Liquid Fill Dosage Form |
PL3228650T3 (pl) | 2014-12-04 | 2022-06-27 | Delta-Fly Pharma, Inc. | Nowa pochodna PEG |
JP6720447B2 (ja) | 2014-12-18 | 2020-07-08 | ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. | 酸感受性薬剤の送達のための薬剤送達系 |
EP3397276A4 (en) | 2015-12-30 | 2019-12-18 | Kodiak Sciences Inc. | ANTIBODIES AND CONJUGATES THEREOF |
CN107375288B (zh) | 2016-05-16 | 2019-08-23 | 博瑞生物医药(苏州)股份有限公司 | 多臂的聚合靶向抗癌偶联物 |
EP3496760B1 (en) * | 2016-08-09 | 2022-02-09 | The University of Liverpool | Ophthalmic compositions |
AU2018207283B2 (en) | 2017-01-10 | 2024-02-15 | Nektar Therapeutics | Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods |
JP2020105072A (ja) * | 2017-03-24 | 2020-07-09 | 協和キリン株式会社 | ポリエチレングリコール誘導体 |
EP3613792B1 (en) * | 2017-04-21 | 2021-02-24 | Bright Gene Bio-Medical Technology Co., Ltd. | Multi-arm targeted anti-cancer conjugate |
CN108727584B (zh) * | 2017-04-21 | 2021-01-05 | 博瑞生物医药(苏州)股份有限公司 | 抗癌偶联物 |
CN111051512A (zh) | 2017-07-11 | 2020-04-21 | 辛索克斯公司 | 非天然核苷酸的掺入及其方法 |
WO2019028425A1 (en) | 2017-08-03 | 2019-02-07 | Synthorx, Inc. | CONJUGATES OF CYTOKINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES |
CN109776787B (zh) * | 2017-11-14 | 2021-08-03 | 博瑞生物医药(苏州)股份有限公司 | 多臂靶向偶联物 |
CN109771658B (zh) * | 2017-11-14 | 2021-12-10 | 博瑞生物医药(苏州)股份有限公司 | 靶向多臂偶联物 |
WO2019096096A1 (zh) * | 2017-11-14 | 2019-05-23 | 博瑞生物医药(苏州)股份有限公司 | 多臂靶向偶联物 |
CN109776788B (zh) * | 2017-11-14 | 2021-07-30 | 博瑞生物医药(苏州)股份有限公司 | 叶酸受体靶向多臂偶联物 |
WO2019136453A1 (en) * | 2018-01-08 | 2019-07-11 | The Regents Of The University Of Colorado, A Body Corporate | 3d in vitro models of lung tissue |
EP3737383A4 (en) | 2018-01-12 | 2021-12-15 | Prolynx LLC | SYNERGISTIC CANCER TREATMENT |
MX2021003116A (es) | 2018-09-17 | 2021-05-14 | Childrens Hospital Philadelphia | Profarmacos macromoleculares a base de polimero. |
US11202834B2 (en) | 2018-10-16 | 2021-12-21 | Rensselaer Polytechnic Institute | Synthesis and processing of poly(pro-drug) materials for extended drug release and uses thereof |
AU2020218203A1 (en) | 2019-02-06 | 2021-08-26 | Synthorx, Inc. | IL-2 conjugates and methods of use thereof |
CN111603567A (zh) | 2019-02-22 | 2020-09-01 | 博瑞生物医药(苏州)股份有限公司 | Cd44靶向多臂偶联物 |
EP3969488A1 (en) * | 2019-08-28 | 2022-03-23 | Boston Scientific Scimed Inc. | Multi-armed polymers comprising free-radical-polymerizable monomers |
EP3958907A1 (en) * | 2019-08-28 | 2022-03-02 | Boston Scientific Scimed Inc. | Multi-armed polyoxazolines and compositions, systems and methods pertaining to the same |
WO2021050554A1 (en) | 2019-09-10 | 2021-03-18 | Synthorx, Inc. | Il-2 conjugates and methods of use to treat autoimmune diseases |
EP4041312A4 (en) | 2019-10-10 | 2023-12-20 | Kodiak Sciences Inc. | METHOD FOR TREATING AN EYE DISORDER |
JP2022554272A (ja) | 2019-11-04 | 2022-12-28 | シンソークス, インコーポレイテッド | インターロイキン10コンジュゲートおよびその使用 |
US11524078B2 (en) | 2020-05-14 | 2022-12-13 | Delta-Fly Pharma, Inc. | Water-soluble macromolecular derivative of Venetoclax |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
US5080891A (en) | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
US5281698A (en) | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
WO1993024476A1 (en) * | 1992-06-04 | 1993-12-09 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
US5614549A (en) * | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5965566A (en) * | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5840900A (en) * | 1993-10-20 | 1998-11-24 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5880131A (en) * | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5919455A (en) * | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5605976A (en) * | 1995-05-15 | 1997-02-25 | Enzon, Inc. | Method of preparing polyalkylene oxide carboxylic acids |
US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
US5629384A (en) | 1994-05-17 | 1997-05-13 | Consiglio Nazionale Delle Ricerche | Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces |
US5650234A (en) | 1994-09-09 | 1997-07-22 | Surface Engineering Technologies, Division Of Innerdyne, Inc. | Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
US5693609A (en) | 1994-11-17 | 1997-12-02 | Eli Lilly And Company | Acylated insulin analogs |
IL117684A (en) * | 1995-04-07 | 2002-02-10 | Pharmacia & Upjohn Inc | Intermediates and Process for Production of History of Kempotocin (CPT-11) and Related Compounds |
US5726181A (en) * | 1995-06-05 | 1998-03-10 | Bionumerik Pharmaceuticals, Inc. | Formulations and compositions of poorly water soluble camptothecin derivatives |
EP0886648B8 (en) | 1995-06-07 | 2004-03-03 | Ortho Pharmaceutical Corporation | Compounds and peptides that bind to the erythropoietin receptor |
US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
CN1304058C (zh) | 1996-03-12 | 2007-03-14 | Pg-Txl有限公司 | 水溶性紫杉醇产品 |
FR2746308B1 (fr) | 1996-03-22 | 1998-04-30 | Oreal | Compositions de teinture des fibres keratiniques contenant des imidazolo-azoles ; leur utilisation en teinture comme coupleurs ; procede de teinture |
GB9721069D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Polymeric derivatives of camptothecin |
US6011042A (en) * | 1997-10-10 | 2000-01-04 | Enzon, Inc. | Acyl polymeric derivatives of aromatic hydroxyl-containing compounds |
US6111107A (en) * | 1997-11-20 | 2000-08-29 | Enzon, Inc. | High yield method for stereoselective acylation of tertiary alcohols |
US6624142B2 (en) * | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
EP1061954B1 (en) | 1998-03-12 | 2004-06-09 | Nektar Therapeutics Al, Corporation | Poly(ethylene glycol) derivatives with proximal reactive groups |
US6153655A (en) | 1998-04-17 | 2000-11-28 | Enzon, Inc. | Terminally-branched polymeric linkers and polymeric conjugates containing the same |
DE29812626U1 (de) | 1998-07-15 | 1998-11-12 | Scm Microsystems Gmbh | Kartenleser für Chipkarten |
EP1176985A2 (en) | 1999-04-28 | 2002-02-06 | Vectramed, Inc. | Enzymatically activated polymeric drug conjugates |
WO2000066125A1 (en) * | 1999-04-29 | 2000-11-09 | Aventis Pharma S.A. | Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
US6541508B2 (en) | 1999-09-13 | 2003-04-01 | Nobex Corporation | Taxane prodrugs |
WO2001046291A1 (en) * | 1999-12-22 | 2001-06-28 | Shearwater Corporation | Sterically hindered derivatives of water soluble polymers |
US20040009229A1 (en) * | 2000-01-05 | 2004-01-15 | Unger Evan Charles | Stabilized nanoparticle formulations of camptotheca derivatives |
US6602498B2 (en) * | 2000-02-22 | 2003-08-05 | Shearwater Corporation | N-maleimidyl polymer derivatives |
AU2001257577A1 (en) * | 2000-02-28 | 2001-09-03 | Shearwater Corporation | Water-soluble polymer conjugates of artelinic acid |
US6629995B1 (en) | 2000-03-31 | 2003-10-07 | Super Gen, Inc. | Camptothecin conjugates |
US6777387B2 (en) * | 2000-03-31 | 2004-08-17 | Enzon Pharmaceuticals, Inc. | Terminally-branched polymeric linkers containing extension moieties and polymeric conjugates containing the same |
US6756037B2 (en) * | 2000-03-31 | 2004-06-29 | Enzon, Inc. | Polymer conjugates of biologically active agents and extension moieties for facilitating conjugation of biologically active agents to polymeric terminal groups |
MXPA03000481A (es) | 2000-07-21 | 2004-09-09 | Schlumberger Technology Bv | Metodos de resonancia magnetica nuclear para extraer informacion sobre un fluido en una formacion rocosa. |
WO2002043772A2 (en) | 2000-11-30 | 2002-06-06 | Shearwater Corporation | Water-soluble polymer conjugates of triazine derivatives |
US8552054B2 (en) * | 2001-03-23 | 2013-10-08 | Luitpold Pharmaceuticals, Inc. | Fatty amine drug conjugates |
US20030108556A1 (en) * | 2001-06-08 | 2003-06-12 | Mekalanos John J. | Therapeutic uses of polyvalent compositions in infectious diseases |
WO2003033525A1 (en) | 2001-10-12 | 2003-04-24 | Debio Recherche Pharmacuetique S.A. | Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament |
MXPA04004026A (es) * | 2001-10-29 | 2004-07-08 | Nektar Therapeutics Al Corp | Conjugados polimericos de inhibidores de la proteina quinasa c. |
JP2005507934A (ja) * | 2001-10-30 | 2005-03-24 | ネクター セラピューティックス エイエル,コーポレイション | レチノイン酸の水溶性ポリマー結合体 |
US6608076B1 (en) * | 2002-05-16 | 2003-08-19 | Enzon, Inc. | Camptothecin derivatives and polymeric conjugates thereof |
EP1553935A4 (en) * | 2002-06-06 | 2010-07-07 | Univ Washington | METHODS OF USING ARTEMISININE-TYPE COMPOUNDS TO PREVENT OR DELAY THE APPEARANCE OF CANCER |
US7122189B2 (en) * | 2002-08-13 | 2006-10-17 | Enzon, Inc. | Releasable polymeric conjugates based on aliphatic biodegradable linkers |
ES2377318T3 (es) * | 2002-09-06 | 2012-03-26 | Cerulean Pharma Inc. | Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos |
PT1675622T (pt) | 2003-09-17 | 2017-09-19 | Nektar Therapeutics | Pró-fármacos de polímeros de múltiplos braços |
-
2004
- 2004-09-17 PT PT47845607T patent/PT1675622T/pt unknown
- 2004-09-17 BR BRPI0414017A patent/BRPI0414017B8/pt active IP Right Grant
- 2004-09-17 SI SI200432402T patent/SI1675622T1/sl unknown
- 2004-09-17 KR KR1020067007403A patent/KR101200729B1/ko active IP Right Grant
- 2004-09-17 HU HUE04784560A patent/HUE036290T2/hu unknown
- 2004-09-17 EP EP13164490.8A patent/EP2626083A1/en not_active Withdrawn
- 2004-09-17 US US10/943,799 patent/US7744861B2/en active Active
- 2004-09-17 LT LTEP04784560.7T patent/LT1675622T/lt unknown
- 2004-09-17 DK DK04784560.7T patent/DK1675622T3/en active
- 2004-09-17 CN CN2004800268096A patent/CN1852740B/zh active Active
- 2004-09-17 AU AU2004274489A patent/AU2004274489B2/en not_active Ceased
- 2004-09-17 PL PL04784560T patent/PL1675622T3/pl unknown
- 2004-09-17 ES ES04784560.7T patent/ES2629696T3/es active Active
- 2004-09-17 JP JP2006527105A patent/JP5632119B2/ja not_active Expired - Fee Related
- 2004-09-17 CN CN201110070872.1A patent/CN102172405B/zh active Active
- 2004-09-17 EP EP04784560.7A patent/EP1675622B1/en active Active
- 2004-09-17 WO PCT/US2004/030720 patent/WO2005028539A2/en active Application Filing
- 2004-09-17 KR KR1020127015575A patent/KR20120073370A/ko not_active Application Discontinuation
- 2004-09-17 CA CA2537336A patent/CA2537336C/en active Active
-
2008
- 2008-02-11 US US12/069,727 patent/US20080194612A1/en not_active Abandoned
-
2010
- 2010-02-22 US US12/709,800 patent/US8263062B2/en active Active
- 2010-03-19 US US12/728,072 patent/US8318145B2/en active Active
-
2011
- 2011-05-24 AU AU2011202402A patent/AU2011202402B2/en not_active Ceased
- 2011-06-21 JP JP2011137790A patent/JP6166014B2/ja not_active Expired - Fee Related
-
2014
- 2014-06-10 JP JP2014119823A patent/JP2014196321A/ja active Pending
-
2017
- 2017-03-13 JP JP2017047691A patent/JP2017119706A/ja active Pending
- 2017-07-17 HR HRP20171094TT patent/HRP20171094T1/hr unknown
- 2017-08-17 CY CY20171100875T patent/CY1119303T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1675622T1 (sl) | Večkraka polimerna predzdravila | |
GB0306907D0 (en) | Boireductively-activated prodrugs | |
EP1620450A4 (en) | POLYMER OLIGONUCLEOTIDE PRODRUGS | |
ZA200409675B (en) | Hyperbranched polymers | |
GB2412111B (en) | Polymeric void-board | |
GB0321383D0 (en) | Polymer circuits | |
DE60333033D1 (en) | Pulverförmiges thermoplastisches polymer | |
IL183137A0 (en) | Polymeric nano-shells | |
GB0423212D0 (en) | Polymer | |
GB2418921B (en) | Antimicrobial polymers | |
GB2423992B (en) | Alkoxylated alkylphenol-formaldehyde-diamine polymer | |
EP1686681A4 (en) | POLYMER ACTUATOR | |
AU2003267540A8 (en) | Biodegradable polymer | |
GB2393446B (en) | Polymer | |
EP1657978A4 (en) | ANTIMICROBIAL ACRYLIC POLYMER | |
GB0327135D0 (en) | Hyperbranched polymers | |
HK1092171A1 (en) | Polymer networks | |
GB2398790B (en) | Polymer compositions | |
GB0310858D0 (en) | Polymer transistor | |
GB0313441D0 (en) | Polymeric surfactant | |
GB0310335D0 (en) | Biodegradable polymer | |
GB0511841D0 (en) | Polymer formulations | |
GB0426282D0 (en) | Polymer scaffold | |
GB0309010D0 (en) | Polymer networks | |
GB0327634D0 (en) | Polymer scaffold |